ENMD-0995 (S 3-APG), a novel thalidomide analogue, has promising clinical activity for patients with relapsed refractory multiple myeloma. Preliminary results of a phase I clinical trial.

被引：0
|
作者：
Lacy, MQ
Dispenzieri, A
Gertz, MA
Wilzig, TE
Greipp, PR
Fonseca, R
Lust, JA
Kumar, S
Zeldenrust, S
Kyle, RA
Snow, D
Hayman, SR
Sidor, CF
Treston, AM
Zeldis, JB
Rajkumar, SV
机构：
[1] Celgene Corp, Warren, NJ USA
[2] Entremed Inc, Rockford, IL USA
[3] Mayo Clin, Rochester, MN USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1654
引用
收藏
页码：453A / 453A
页数：1
相关论文
共 50 条
  • [1] Bendamustine in combination with thalidomide and prednisone in patients with refractory or relapsed multiple myeloma. preliminary results of a phase I clinical trial
    Pönisch, W
    Rozanski, M
    Leiblein, S
    Goldschmidt, H
    Wegner, A
    Niederwieser, D
    ANNALS OF ONCOLOGY, 2005, 16 : 208 - 208
  • [2] Bendamustine in combination with thalidomide and prednisolone (BPT) in patients with refractory or relapsed multiple myeloma (MM): Preliminary results of a phase I clinical trial.
    Poenisch, W
    Rozanski, M
    Leiblein, S
    Goldschmidt, H
    Wegner, A
    Niederwieser, D
    BLOOD, 2004, 104 (11) : 307B - 307B
  • [3] Bendamustine in combination with thalidomide and prednisolone (BPT) in patients with refractory or relapsed multiple myeloma: Results of a phase I clinical trial.
    Poenisch, W.
    Rozanski, M.
    Hoffmann, F.
    Boldt, T.
    Schwarzer, A.
    Ruffert, U.
    Rohrberg, R.
    Kreibich, U.
    Niederwieser, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 451S - 451S
  • [4] Lenalidomide in combination with Bendamustine and Prednisolone (RBP) in patients with refractory or relapsed multiple myeloma. Preliminary results of a phase I clinical trial
    Poenisch, W.
    Heyn, S.
    Wagner, I
    Mohren, M.
    Hoffmann, F. A.
    Schueler, F.
    Al-Ali, H. K.
    Jaekel, N.
    Niederwieser, D.
    ONKOLOGIE, 2010, 33 : 156 - 156
  • [5] Pre-clinical evaluation of a thalidomide analog with activity against multiple myeloma and solid tumors - ENMD-0995 (S-(-)3-(3-amino-phthalimido)-glutarimide).
    Treston, AM
    Swartz, GM
    Conner, B
    Shah, J
    Pribluda, VS
    BLOOD, 2002, 100 (11) : 816A - 816A
  • [6] A Phase I Clinical Trial Testing the Combination of Bortezomib and Tipifarnib in Relapsed/Refractory Multiple Myeloma.
    Lonial, Sagar
    Francis, Dixil
    Karanes, Chatchada
    Trudel, Suzanne
    Dollard, Akari M.
    Aceo, Fermin
    Gul, Engin
    Kakar, Sumeet
    Krishnan, Amrita Y.
    Reece, Donna E.
    Harvey, R. Donald
    Kaufman, Jonathan L.
    BLOOD, 2009, 114 (22) : 1481 - 1481
  • [7] Combination of bortezomib, melphalan, prednisone and thalidomide (VMPT) for relapsed multiple myeloma: Results of a phase I/II clinical trial.
    Palumbo, Antonio
    Ambrosini, Maria Teresa
    Benevolo, Giulia
    Pregno, Patrizia
    Pescosta, Norbert
    Callea, Vincenzo
    Cangialosi, Clotilde
    Caravita, Tommaso
    Morabito, Fortunato
    Musto, Legrino
    Bringhen, Sara
    Gay, Francesca
    Rus, Cecilia
    Boccadoro, Mario
    BLOOD, 2006, 108 (11) : 125A - 125A
  • [8] Combined Bendamustine, Prednisolone and Lenalidomide (RBP) In Refractory or Relapsed Multiple Myeloma. First Results of a Phase I Clinical Trial
    Ponisch, Wolfram
    Heyn, Simone
    Wagner, Ina
    Mohren, Martin
    Hoffmann, Franz-Albert
    Schueler, Frank
    Schmalfeld, Marion
    Al-Ali, Haifa K.
    Jaekel, Nadja
    Niederwieser, Dietger W.
    BLOOD, 2010, 116 (21) : 823 - 824
  • [9] Lenalidomid combined with Bendamustine, Prednisolone (RBP) in patients with refractory or relapsed multiple myeloma. Final results of a phase I clinical trial -OSHO - #077
    Poenisch, W.
    Heyn, S.
    Wagner, I
    Mohren, M.
    Hoffmann, F. A.
    Lange, T.
    Schmalfeld, M.
    Zehrfeld, T.
    Schwarzer, A.
    Winkelmann, C.
    Edelmann, T.
    Hebenstreit, K.
    Al-Ali, H. K.
    Jaekel, N.
    Niederwieser, D.
    ONKOLOGIE, 2012, 35 : 160 - 160
  • [10] COMBINED BENDAMUSTINE, PREDNISOLONE AND LENALIDOMIDE (RBP) IN PATIENTS WITH REFRACTORY OR RELAPSED MULTIPLE MYELOMA. FINAL RESULTS OF A PHASE I CLINICAL TRIAL - OSHO - #077
    Poenisch, W.
    Heyn, S.
    Wagner, I.
    Mohren, M.
    Hoffmann, F. A.
    Lange, T.
    Schmalfeld, M.
    Zehrfeld, T.
    Schwarzer, A.
    Winkelmann, C.
    Edelmann, T.
    Roehrborn, R.
    Al-Ali, H.
    Jaekel, J.
    Niederwieser, D.
    HAEMATOLOGICA, 2012, 97 : 348 - 348
12345